Showing results (131-140 of 219) with videos related to
Sort By:
Pageof 22
Plos One|April 18, 2013
Immune biomarker differences and changes comparing HCV mono-infected, HIV/HCV co-infected, and HCV spontaneously cleared patientsLauren E Kushner, Aaron M Wendelboe, Laura C Lazzeroni, et al.Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|November 1, 2013
Impaired HCV clearance in HIV/HCV coinfected subjects treated with PegIFN and RBV due to interference of IFN signaling by IFNαR2aYu-Jin Lee, Xiaozhen Zhang, Estefania Vazquez, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 5, 2019
Testosterone in Men With Chronic Hepatitis C Infection and After Hepatitis C Viral ClearanceChloe S Chaudhury, Thomas Mee, Cheryl Chairez, et al.Proceedings of the National Academy of Sciences of the United States of America|December 3, 2003
Natural killer cells in HIV-1 infection: dichotomous effects of viremia on inhibitory and activating receptors and their functional correlatesDomenico Mavilio, Janet Benjamin, Marybeth Daucher, et al.AIDS (London, England)|August 19, 2004
Serious ophthalmic pathology compromising vision in HCV/HIV co-infected patients treated with peginterferon alpha-2b and ribavirinClaire Farel, Daniel L Suzman, Mary McLaughlin, et al.AIDS Research and Human Retroviruses|May 25, 2013
Short communication: Interferon/ribavirin treatment for HCV is associated with the development of hypophosphatemia in HIV/hepatitis C virus-coinfected patientsEmily K Funk, Ashton Shaffer, Bhavana Shivakumar, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|June 26, 2012
Gene expression profiles predict emergence of psychiatric adverse events in HIV/HCV-coinfected patients on interferon-based HCV therapyJoseph Rasimas, Antonios Katsounas, Haniya Raza, et al.Proceedings of the National Academy of Sciences of the United States of America|February 26, 2004
Relationship between the frequency of HIV-specific CD8+ T cells and the level of CD38+CD8+ T cells in untreated HIV-infected individualsTae-Wook Chun, J Shawn Justement, Christina Sanford, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|January 27, 2010
HIV/Hepatitis C virus-coinfected virologic responders to pegylated interferon and ribavirin therapy more frequently incur interferon-related adverse events than nonresponders doAnu Osinusi, Joseph J Rasimas, Rachel Bishop, et al.Medrxiv : the Preprint Server for Health Sciences|August 15, 2020
Specificity and Performance of Nucleocapsid and Spike-based SARS-CoV-2 Serologic AssaysZahra Rikhtegaran Tehrani, Saman Saadat, Ebtehal Saleh, et al.Pageof 22